|
1
|
Mirimanoff R-O: High-grade gliomas:
Reality and hopes. Chin J Cancer. 33:1–3. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stupp R, Mason WP, Van Den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: Radiotherapy plus concomitant and adjuvant temozolomide
for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stupp R, Hegi ME, Mason WP, van den Bent
MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B,
Belanger K, et al: Effects of radiotherapy with concomitant and
adjuvant temozolomide versus radiotherapy alone on survival in
glioblastoma in a randomised phase III study: 5-year analysis of
the EORTC-NCIC trial. Lancet Oncol. 10:459–466. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chang C, Horton J, Schoenfeld D, Salazer
O, Perez-Tamayo R, Kramer S, Weinstein A, Nelson J and Tsukada Y:
Comparison of postoperative radiotherapy and combined postoperative
radiotherapy and chemotherapy in the multidisciplinary management
of malignant gliomas. A joint Radiation Therapy Oncology Group and
Eastern Cooperative Oncology Group study. Cancer. 52:997–1007.
1983. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nelson DF, Curran WJ Jr, Scott C, Nelson
JS, Weinstein AS, Ahmad K, Constine LS, Murray K, Powlis WD,
Mohiuddin M, et al: Hyperfractionated radiation therapy and
bis-chlorethyl nitrosourea in the treatment of malignant glioma -
possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions:
Report of the Radiation Therapy Oncology Group protocol 8302. Int J
Radiat Oncol Biol Phys. 25:193–207. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Urtasun RC, Kinsella TJ, Farnan N, DelRowe
JD, Lester SG and Fulton DS: Survival improvement in anaplastic
astrocytoma, combining external radiation with halogenated
pyrimidines: Final report of RTOG 86-12, phase I–II study. Int J
Radiat Oncol Biol Phys. 36:1163–1167. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Colman H, Berkey BA, Maor MH, Groves MD,
Schultz CJ, Vermeulen S, Nelson DF, Mehta MP and Yung WK: Radiation
Therapy Oncology Group: Phase II Radiation Therapy Oncology Group
trial of conventional radiation therapy followed by treatment with
recombinant interferon-beta for supratentorial glioblastoma:
Results of RTOG 9710. Int J Radiat Oncol Biol Phys. 66:818–824.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chang EL, Akyurek S, Avalos T, Rebueno N,
Spicer C, Garcia J, Famiglietti R, Allen PK, Chao KC, Mahajan A, et
al: Evaluation of peritumoral edema in the delineation of
radiotherapy clinical target volumes for glioblastoma. Int J Radiat
Oncol Biol Phys. 68:144–150. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Minniti G, Amelio D, Amichetti M, Salvati
M, Muni R, Bozzao A, Lanzetta G, Scarpino S, Arcella A and Enrici
RM: Patterns of failure and comparison of different target volume
delineations in patients with glioblastoma treated with conformal
radiotherapy plus concomitant and adjuvant temozolomide. Radiother
Oncol. 97:377–381. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Brandes AA, Stupp R, Hau P, Lacombe D,
Gorlia T, Tosoni A, Mirimanoff RO, Kros JM and van den Bent MJ:
EORTC study 26041–22041: Phase I/II study on concomitant and
adjuvant temozolomide (TMZ) and radiotherapy (RT) with
PTK787/ZK222584 (PTK/ZK) in newly diagnosed glioblastoma. Eur J
Cancer. 46:348–354. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wen PY, Macdonald DR, Reardon DA,
Cloughesy TF, Sorensen AG, Galanis E, DeGroot J, Wick W, Gilbert
MR, Lassman AB, et al: Updated response assessment criteria for
high-grade gliomas: Response assessment in Neuro-Oncology Working
Group. J Clin Oncol. 28:1963–1972. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
de Wit MC, de Bruin HG, Eijkenboom W,
Sillevis Smitt PA and van den Bent MJ: Immediate post-radiotherapy
changes in malignant glioma can mimic tumor progression. Neurology.
63:535–537. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Taal W, Brandsma D, de Bruin HG, Bromberg
JE, Swaak-Kragten AT, Smitt PA, van Ews CA and van den Bent MJ:
Incidence of early pseudo-progression in a cohort of malignant
glioma patients treated with chemoirradiation with temozolomide.
Cancer. 113:405–410. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chaskis C, Neyns B, Michotte A, De Ridder
M and Everaert H: Pseudoprogression after radiotherapy with
concurrent temozolomide for high-grade glioma: Clinical
observations and working recommendations. Surg Neurol. 72:423–428.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Brandes AA, Franceschi E, Tosoni A, Blatt
V, Pession A, Tallini G, Bertorelle R, Bartolini S, Calbucci F,
Andreoli A, Frezza G, Leonardi M, Spagnolli F and Ermani M: MGMT
promoter methylation status can predict the incidence and outcome
of pseudoprogression after concomitant radiochemotherapy in newly
diagnosed glioblastoma patients. J Clin Oncol. 26:2192–2197. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Brandsma D, Stalpers L, Taal W, Sminia P
and van den Bent MJ: Clinical features, mechanisms, and management
of pseudoprogression in malignant gliomas. Lancet Oncol. 9:453–461.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee SW, Fraass BA, Marsh LH, Herbort K,
Gebarski SS, Martel MK, Radany EH, Lichter AS and Sandler HM:
Patterns of failure following high-dose 3-D conformal radiotherapy
for high-grade astrocytomas: A quantitative dosimetric study. Int J
Radiat Oncol Biol Phys. 43:79–88. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chan JL, Lee SW, Fraass BA, Normolle DP,
Greenberg HS, Junck LR, Gebarski SS and Sandler HM: Survival and
failure patterns of high-grade gliomas after three-dimensional
conformal radiotherapy. J Clin Oncol. 20:1635–1642. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Andersen AP: Postoperative irradiation of
glioblastomas. Results in a randomized series. Acta Radiol Oncol
Radiat Phys Biol. 17:475–484. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Walker MD, Alexander E Jr, Hunt WE,
MacCarty CS, et al: Evaluation of BCNU and/or radiotherapy in the
treatment of anaplastic gliomas. A cooperative clinical trial. J
Neurosurg. 49:333–343. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shapiro WR and Young DF: Treatment of
malignant glioma. A controlled study of chemotherapy and
irradiation. Arch Neurol. 33:494–500. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wallner KE, Galicich JH, Krol G, Arbit E
and Malkin MG: Patterns of failure following treatment for
glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat
Oncol Biol Phys. 16:1405–1409. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shapiro WR, Green SB, Burger PC, et al:
Randomized trial of three chemotherapy regimens and two
radiotherapy regimens and two radiotherapy regimens in
postoperative treatment of malignant glioma. Brain Tumor
Cooperative Group Trial 8001. J Neurosurg. 71:1–9. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Milano MT, Okunieff P, Donatello RS,
Mohile NA, Sul J, Walter KA and Korones DN: Patterns and timing of
recurrence after temozolomide-based chemoradiation for
glioblastoma. Int J Radiat Oncol Biol Phys. 78:1147–1155. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
McDonald MW, Shu H-KG, Curran WJ and
Crocker IR: Pattern of failure after limited margin radiotherapy
and temozolomide for glioblastoma. Int J Radiat Oncol Biol Phys.
79:130–136. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sherriff J, Tamangani J, Senthil L,
Cruickshank G, Spooner D, Jones B, Brookes C and Sanghera P:
Patterns of relapse in glioblastoma multiforme following
concomitant chemoradiotherapy with temozolomide. Br J Radiol.
86:201204142013. View Article : Google Scholar : PubMed/NCBI
|
